# A Study to Evaluate EDG-7500 in People With Renal Impairment

> **NCT07034768** · PHASE1 · COMPLETED · sponsor: **Edgewise Therapeutics, Inc.** · enrollment: 37 (actual)

## Conditions studied

- Renal Impairments

## Interventions

- **DRUG:** EDG-7500

## Key facts

- **NCT ID:** NCT07034768
- **Lead sponsor:** Edgewise Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-22
- **Primary completion:** 2025-12-22
- **Final completion:** 2025-12-26
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07034768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07034768, "A Study to Evaluate EDG-7500 in People With Renal Impairment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07034768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*